Importance The COVID-19 pandemic saw one of the fastest developments of vaccines in an
effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine …

Introduction The World Health Organization declared the coronavirus disease 2019 (COVID-
19) pandemic on March 11, 2020. Two vaccine types were developed using two different …

Background: As of 8 April 2021, a total of 2.9 million people have died with or from the
coronavirus infection causing COVID-19 (Corona Virus Disease 2019). On 29 January 2021 …

Background There are concerns about a link between the ChAdOx1 nCoV-19 and Ad26.
COV2. S vaccines against COVID-19 and cerebral venous thrombosis (CVT) and other …

Background and purpose Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)
infection predisposes patients to arterial and venous thrombosis. This study aimed to …

Carbohydrates are fundamental molecules involved in nearly all aspects of lives, such as
being involved in formating the genetic and energy materials, supporting the structure of …

Background Neuroinflammation-induced injury is intimately associated with poor prognosis
in patients with cerebral venous sinus thrombosis (CVST). The cyclic GMP-AMP synthase …

Importance To date, only uncontrolled studies have evaluated the efficacy and safety of
endovascular treatment (EVT) in patients with cerebral venous thrombosis (CVT), leading to …

Background COVID-19 infection has been known to predispose patients to both arterial and
venous thromboembolic events such as deep venous thrombosis, pulmonary embolism …

Objective Identify clinical and radiographic features of venous infarct as a presenting feature
of COVID-19 in the young. Background SARS-CoV-2 infection causes hypercoagulability …